U.S. markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.09
    -0.27 (-0.52%)
     
  • Gold

    1,836.80
    +6.90 (+0.38%)
     
  • Silver

    25.01
    +0.14 (+0.58%)
     
  • EUR/USD

    1.2080
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • GBP/USD

    1.3582
    -0.0002 (-0.01%)
     
  • USD/JPY

    103.6820
    -0.1180 (-0.11%)
     
  • BTC-USD

    36,535.75
    +796.99 (+2.23%)
     
  • CMC Crypto 200

    708.54
    -26.60 (-3.62%)
     
  • FTSE 100

    6,720.65
    -15.06 (-0.22%)
     
  • Nikkei 225

    28,242.21
    -276.97 (-0.97%)
     

CooperCompanies to Present at J.P. Morgan Healthcare Conference

The Cooper Companies, Inc.
·1 min read

SAN RAMON, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will represent the Company in a presentation scheduled to begin at 12:40PM PT (3:40PM ET).

This webcast will be available to investors and other interested parties by accessing the Investor Relations section of the CooperCompanies website at http://investor.coopercos.com. A webcast replay will be available approximately 24-hours after the live webcast.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com